| Ytd | -73.33% | |
| 1y | -27.41% |
| Open | 2.15 | Prev Close | 2.10 | Low | 2.10 | High | 2.15 | Mkt Cap | 17.66M |
| Vol | 9.27K | Avg Vol | 73.40K | EPS | -1.79 | P/E | -1.20 | Forward P/E | -3.87 |
| Beta | 0.46 | Short Ratio | 2.80 | Inst. Own | 9.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 2.26 | 200-d Avg | 4.56 | 1yr Est | 21.50 |
LPCN News
SALT LAKE CITY, Aug. 4, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutica
/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary
Live webinar to take place on Friday, June 12, 2026 at 11:00 AM Eastern Time SALT LAKE CITY, June 4,
SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical compa
BASEL, Switzerland, May 19, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pio
SALT LAKE CITY, May 18, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical compa
Lipocine (LPCN) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimat
SALT LAKE CITY, May 7, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical compan
Mangoceuticals (NASDAQ: MGRX - Get Free Report) and Lipocine (NASDAQ: LPCN - Get Free Report) are bo
Lipocine Inc. (NASDAQ: LPCN - Get Free Report) Director John Higuchi acquired 40,000 shares of the c
Lipocine Inc. (NASDAQ: LPCN - Get Free Report) CEO Mahesh Patel bought 25,000 shares of the company'
BofA downgrades Carvana (CVNA) to Neutral, cutting the price target to $360. Explore the latest anal
On Thursday, the company said LPCN 1154 did not meet its primary endpoint in a Phase 3 trial for pos
Wall Street analysts changed their outlook on top names. Check out the ratings page for complete cha
SAN DIEGO, April 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims
US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Q
Lipocine said LPCN 1154 did not show a statistically significant reduction from baseline in HAM-D17
In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically
SALT LAKE CITY, March 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical com
Lipocine (LPCN) saw its shares surge in the last session with trading volume being higher than avera
SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical comp
SALT LAKE CITY, Jan. 20, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical comp
VANCOUVER, British Columbia, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider. com News Commentary -
During Thursday's session, 406 companies made new 52-week lows.
Friday's session saw 100 companies set new 52-week lows.
On Friday, 497 companies set new 52-week lows.
On Tuesday, 456 stocks hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Monday, 195 stocks hit new 52-week lows.
On Friday, 109 stocks hit new 52-week lows.
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday.
Gainers Asensus Surgical, Inc. (NYSE: ASXC) shares surged 34.4% to $2.7282. HC Wainwright & C
Gainers Marathon Patent Group, Inc. (NASDAQ: MARA) shares surged 88.7% to close at $3.83 on Mond
Gainers Ambow Education Holding Ltd. (NYSE: AMBO) shares jumped 65.3% to $3.6369.
Stocks That Hit 52-Week Lows On Wednesday
70 Biggest Movers From Yesterday
Stocks That Hit 52-Week Lows On Thursday
58 Biggest Movers From Yesterday
Mid-Afternoon Market Update: Qurate Retail Gains On Upbeat Earnings; ASLAN Pharmaceuticals Shares Sl
68 Biggest Movers From Yesterday
Attention Biotech Investors: Brace For These January PDUFA Events